On this week's episode of Joint Action, Professor Christian Barton unpacks the blind spots in osteoarthritis research, exploring who has and hasn't been included in the evidence base for first-line care, and what that means for the patients we treat every day.Prof Christian Barton is a physiotherapist and implementation scientist at La Trobe University, where he leads key projects including GLA:D Australia and TREK
These data highlight a potential therapeutic approach to targeting endogenous GLP-1-producing anti-craving circuits to reduce cocaine relapse and further support of the translational potential of GLP-1R agonists as pharmacotherapies for CUD
The imbalance, the Trump administration says, provides incentives for drug companies to invest in large molecule drugs, known as biologics, which arent subject to negotiation for 13 years after approval by the Food and Drug Administration
A full evaluation with a healthcare provider is required to confirm if retatrutide is appropriate, and success hinges on combining medication with sustainable lifestyle adjustments